The Foundation for Women’s Cancer and the Society of Gynecologic Oncologists provide a “guidance to women,” that is distributed via the Foundation for Women’s Cancer’s Allied Support Group (ASG) when new findings are announced or when SGO issues a new position statement that requires clarification in order to ensure an accurate understanding of the new findings or position statement on the part of gynecologic survivors and the larger community.
Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.
Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.
The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.